Recommendations for the treatment of hypertension in the elderly and very elderly - A scotoma within international guidelines

Swiss Medical Weekly

Volumn 142, Issue MAY, 2012, Pages

  Schäfer, Hans Hendrik ^a   De Villiers, Jacob N ^e   Sudano, Isabella ^b   Dischinger, Sandra ^c   Theus, Gian Reto ^d   Zilla, Peter ^a   Dieterle, Thomas ^f  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Novartis Pharma Schweiz AG   (Switzerland)

^d Healthworld Schweiz AG   (Switzerland)

^e UNIVERSITY OF STELLENBOSCH   (South Africa)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Blood pressure; Elderly; Hypertension; International guidelines; Treatment

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENDROFLUMETHIAZIDE; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; INDAPAMIDE; SARTAN DERIVATIVE;

AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONSENSUS; DRUG DOSE ESCALATION; DRUG EFFICACY; EDEMA; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; INCIDENCE; MEDICAL EDUCATION; MORBIDITY; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PERIPHERAL EDEMA; POLYPHARMACY; PRACTICE GUIDELINE; REVIEW; SCOTOMA; SYSTOLIC HYPERTENSION; VASOCONSTRICTION; VERY ELDERLY;

EID: 84878675605     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2012.13574     Document Type: Review

References (34)

1. Alcocer L, Cueto L. Hypertension, a health economics perspective. Ther Adv Cardiovasc Dis. 2008;2(3):147-55.
2. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46-e215.
3. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly; A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration With the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens. 2011;5(4):259-352.
4. World Population Data Sheet. 2010; Available from: http://www.prb.org/ pdf10/10wpds-eng.pdf.
5. Mansia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105-87. (Pubitemid 46924065)
6. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27(11):2121-58.
7. Quinn RR, Hemmelgarn BR, Padwal RS, Myers MG, Cloutier L, Bolli P, et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol. 2010;26(5):241-8.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72. (Pubitemid 37430158)
9. National Institute for Health Excellence (NICE). Hypertension: management of hypertension in adults in primary care. 2006; Available from: http://www.nice.org.uk/CG034
10. Deutsche Hochdruck Liga (DHL). Leitlinien zur Behandlung der arteriellen Hypertonie. 2008; Available from: http://www.awmf.org/uploads/tx-szleitlinien/ 046-001-S2-Behandlung-der-arteriellen-Hypertonie-06-2008-06-2013.pdf
11. Swiss Society of Hypertension (SSH). Guidelines 2009; http://www.swisshypertension.ch/guidelines.htm
12. Kochanek KD, Smith BL. Deaths: preliminary data for 2002. Natl Vital Stat Rep. 2004;52(13):1-47.
13. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887-98. (Pubitemid 351620109)
14. European Society of Hypertension-European Society of Cardiology Guidelines Committee, 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21(6):1011-53.
15. JATOS study group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31(12):2115-27.
16. Zanchetti A, Grassi G, Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens. 2009;27(5):923-34.
17. Hajjar I, Miller K, Hirth V. Age-related bias in the management of hypertension: a national survey of physicians' opinions on hypertension in elderly adults. J Gerontol A Biol Sci Med Sci. 2002;57(8):487-91.
18. Masaki KH, Schatz IJ, Burchfiel CM, Sharp DS, Chiu D, Foley D, et al. Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation. 1998;98(21):2290-5. (Pubitemid 28533848)
19. Cooper-DeHoff RM, Aranda JM Jr, Gaxiola E, Cangiano JL, Garcia-Barreto D, Conti CR, et al. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients - findings from the International Verapamil SR/Trandolapril Study (INVEST). Am Heart J. 2006;151(5):1072-9.
20. Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, et al. Usual versus tight control of systolic blood pressure in nondiabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet. 2009;374(9689):525-33.
21. Cushman WC, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575-85.
22. Dahlof B, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. (Pubitemid 34286536)
23. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21(5):875-86. (Pubitemid 36677151)
24. Erne P, Allemann Y. Comments to the 2007 recommendations for the treatment of essential hypertension by the Swiss Society of Hypertension. Kardiovaskuläre Medizin. 2008;11:26-8.
25. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338(8778):1281-5.
26. Messerli FH, Grossman E, Goldbourt U. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA. 1998;279(23):1903-7. (Pubitemid 28299288)
27. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417-28.
28. Ruilope LM, et al. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Clin Ther. 2005;27(5):578-87. (Pubitemid 40835968)
29. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326(7404):1427.
30. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97. (Pubitemid 41127293)
31. Hilleman DE, Ryschon KL, Mohiuddin SM, Wurdeman RL. Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation. J Hum Hypertens. 1999;13(7):477-83. (Pubitemid 29355891)
32. Messerli FH, Oparil S, Feng Z. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol. 2000;86(11):1182-7.
33. Low PA. Prevalence of orthostatic hypotension. Clin Auton Res. 2008;18(Suppl 1):8-13. (Pubitemid 351667197)
34. Conen D, Chae CU, Guralnik JM, Glynn RJ. Influence of blood pressure and blood pressure change on the risk of congestive heart failure in the elderly. Swiss Med Wkly. 2010;140(13-14):202-8.